{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:08:03Z","timestamp":1758704883645,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unclear whether zolpidem's potential for delirium might be enhanced when combined with further psychopharmacotherapeutics. The present case report portrays a young male Caucasian inpatient with schizoaffective disorder, who was admitted due to severe hyperactive delirium after a single dose of zolpidem 10 mg that was administered in addition to already established psychopharmacotherapy including clozapine 200 mg\/day, aripiprazole 15 mg\/day and cariprazine 4.5 mg\/day. In detail, disorientation, agitation, confabulations, bizarre behavior, and anterograde amnesia occurred shortly after ingestion of zolpidem and gained in intensity within a couple of hours. Once zolpidem was discontinued, the abovementioned symptoms subsided completely and did not reoccur. Since a clear temporal association could be drawn between the intake of zolpidem and the onset of hyperactive delirium, the present clinical experience should serve as a cautionary note for combining potent sedative-hypnotics and substances with anticholinergic properties, even in young adults in a good general condition. Moreover, our case argues for the necessity of further research into the pathomechanism of the interaction potential of non-benzodiazepines as zolpidem, especially with substances exerting anticholinergic properties, which are known for their potential to precipitate delirium. Therefore, the metabolic pathways of the concurrently administered substances should be further taken into account.<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1204009","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T15:26:23Z","timestamp":1690471583000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine"],"prefix":"10.3389","volume":"14","author":[{"given":"Maximilian","family":"Preiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Rabl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Popper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Watzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Treiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Ivkic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Praschak-Rieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Naderi-Heiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Fugger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Bartova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2165\/00003495-200059040-00014","article-title":"Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia","volume":"59","author":"Holm","year":"2000","journal-title":"Drugs."},{"key":"B2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2165\/00003088-199529030-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of zolpidem: therapeutic implications","volume":"29","author":"Salv\u00e0","year":"1995","journal-title":"Clin Pharmacokinet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/15563650600956741","article-title":"Compulsive activity and anterograde amnesia after zolpidem use","volume":"45","author":"Tsai","year":"2007","journal-title":"Clin Toxicol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/pds.5004","article-title":"Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death","volume":"29","author":"Harbourt","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/NMD.0000000000001074","article-title":"Zolpidem-Associated Consequences: An Updated Literature Review With Case Reports","volume":"208","author":"Westermeyer","year":"2020","journal-title":"J Nerv Ment Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/0253717621992372","article-title":"Zolpidem for insomnia: a double-edged sword. A systematic literature review on zolpidem-induced complex sleep behaviors Indian","volume":"43","author":"Mittal","year":"2021","journal-title":"J Psychol Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","article-title":"The clinical and forensic toxicology of Z-drugs","volume":"9","author":"Gunja","year":"2013","journal-title":"J Med Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00002826-200001000-00011","article-title":"Central nervous system side effects associated with zolpidem treatment","volume":"23","author":"Toner","year":"2000","journal-title":"Clin Neuropharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.12691\/ajmcr-4-4-7","article-title":"Acute delirium caused by single small dose of zolpidem","volume":"4","author":"Tahir","year":"2016","journal-title":"Am J Med Case Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4088\/JCP.v61n0610g","article-title":"Zolpidem-related delirium: a case report","volume":"61","author":"Freudenreich","year":"2000","journal-title":"J Clin Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1345\/aph.10385","article-title":"Delirium associated with Zolpidem","volume":"35","author":"Brodeur","year":"2001","journal-title":"Ann Pharmacother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5664\/jcsm.6452","article-title":"Spontaneous adverse event reports associated with Zolpidem in the United States 2003\u20132012","volume":"13","author":"Wong","year":"2017","journal-title":"J Clinical Sleep Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/practneurol-2018-001998","article-title":"Lyme disease: diagnosis and management","volume":"18","author":"Ross Russell","year":"2018","journal-title":"Pract Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"Doc03","DOI":"10.3205\/000279","article-title":"Guidelines for diagnosis and treatment in neurology\u2014Lyme neuroborreliosis","volume":"18","author":"Rauer","year":"2020","journal-title":"GMS German Med Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"12509","DOI":"10.1038\/s41598-018-30794-y","article-title":"Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor","volume":"8","author":"Frank","year":"2018","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/030006059502300108","article-title":"Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland","volume":"23","author":"Ganzoni","year":"1995","journal-title":"J Int Med Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1365-2125.2011.04009.x","article-title":"Memory disorders associated with consumption of drugs: updating through a case\/noncase study in the French PharmacoVigilance database: drugs and memory","volume":"72","author":"Chavant","year":"2011","journal-title":"Br J Clin Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajp.2016.10.006","article-title":"Zolpidem's use for insomnia","volume":"25","author":"Monti","year":"2017","journal-title":"Asian J Psychiatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12879-016-2112-z","article-title":"Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization","volume":"17","author":"Schwenkenbecher","year":"2017","journal-title":"BMC Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/ijnp\/pyac005","article-title":"Incidence of drug-induced delirium during treatment with antidepressants or antipsychotics: a drug surveillance report of German-speaking countries between 1993 and 2016","volume":"25","author":"Friedrich","year":"2022","journal-title":"Int J Neuropsychopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s40262-018-0664-3","article-title":"Clinical pharmacokinetics of atypical antipsychotics: an update","author":"Mauri","year":"2018","journal-title":"Clin Pharmacokinet"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1204009\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T15:26:40Z","timestamp":1690471600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1204009\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":23,"alternative-id":["10.3389\/fpsyt.2023.1204009"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1204009","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"article-number":"1204009"}}